Status:
UNKNOWN
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
Lead Sponsor:
Kirby Institute
Conditions:
COVID
Eligibility:
All Genders
Brief Summary
The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Elig...
Eligibility Criteria
Inclusion
- Main cohort
- Diagnosed with CoV-SARS-2 infection
- 16 years of age or older
- Have provided informed consent Paediatric cohort
- <!-- -->
- Diagnosed with CoV-SARS-2 infection
- Less than 16 years of age
- Informed consent provided by parent or caregiver
Exclusion
- Main cohort
- <!-- -->
- 15 years of age or younger
- Inability or unwillingness to provide informed consent or abide by the requirements of the study Paediatric cohort
- <!-- -->
- 16 years of age or older
- Inability or unwillingness of parent or caregiver to provide informed consent or abide by the requirements of the study -
Key Trial Info
Start Date :
May 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04383652
Start Date
May 6 2020
End Date
June 30 2022
Last Update
June 29 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
NSW Health Pathology
Randwick, New South Wales, Australia, 2031
2
Prince of Wales Hospital
Randwick, New South Wales, Australia, 2031
3
Sydney Children's Hospital
Randwick, New South Wales, Australia, 2031
4
Blacktown Hospital
Blacktown, Australia